ME-344 FDA Approval Status
FDA Approved: No
Brand name: ME-344
Company: MEI Pharma, Inc.
Treatment for: Ovarian Cancer, Small Cell Lung Cancer
ME-344 is a novel mitochondrial inhibitor in development for the treatment of ovarian cancer and small cell lung cancer.
Development timeline for ME-344
| Date | Article |
|---|---|
| Mar 8, 2012 | Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344 |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.